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Abstract. Gelsolin is a 90,000-mol-wt protein with 
two actin and two high affinity calcium-binding sites 
that can form complexes with Ca  2÷ ions and mono- 
meric actin. These complexes will nucleate filament 
growth and cap the barbed end of filaments, but will 
not fragment F-actin. Uncomplexed gelsolin severs 
F-actin. (Bryan, J., and L. M. Coluccio, 1985, J. Cell 
Biol.,  101:1236-1244).  These associations with actin 
are modulated by Ca  2÷. We have purified and charac- 
terized monoclonal antibodies that recognize Ca2+-in- 
duced conformational changes in human platelet gel- 
solin (G) and human plasma brevin (B), a closely 
related protein. Two hybridomas, 8G5 and 4F8, were 
adapted to growth in serum-free medium. 8G5 was 
found to secrete an IgG; 4F8 secretes an IgA. On 
immunoblots, both antibodies gave a strong reaction 
if Ca  2÷ was present, but gave barely detectable reac- 
tions if EGTA was used. 8G5 IgG-Sepharose columns 
retained gelsolin (as GCa2) or brevin (as BCa2) in 0.1 
mM CaCI2 containing buffers, but released these mol- 
ecules when eluted with 4 mM EGTA. 8G5 IgG-Seph- 
arose columns also retained gelsolin-actin-Ca  2÷ com- 
plexes, as GA,Ca2 or higher oligomers from platelet 
extracts containing 0.1  mM CaC12. Elution with 4 
mM EGTA released material that gel filtration 
showed to be the EGTA-stable 130,000-mol-wt gelso- 
lin-actin complex, GAICa~. The results demonstrate 
that the 8G5 IgG recognizes a conformation of gelso- 
lin or brevin induced by binding of an easily ex- 
changeable Ca  2+ ion. Actin is not required for this 
conformational change, and the antibody discrimi- 
nates, for example, GCa2 from G and GCal. A 4F8 
IgA-Sepharose column retained brevin or gelsolin in 
0.1  mM CaC1E-containing  buffers, but, like the 8G5 
IgG, released these molecules when eluted with 4 mM 
EGTA. The 4F8 IgA column also retained gelsolin or 
brevin-actin-Ca 2÷ complexes, for example, as 
BAjCa2, or higher oligomers, in 0.1  mM CaC12. No 
protein was recovered, however, upon elution with 4 
mM EGTA, but elution with 0.1  M glycine-HCl, pH 
2.8, released bound brevin or gelsolin and actin. Simi- 
larly, preformed brevin-actin-Ca  2+ complex, equili- 
brated with EGTA, was retained by 4F8 IgA-Sepha- 
rose. The results demonstrate that the 4F8 IgA recog- 
nizes a conformation of gelsolin or brevin that is 
maintained and presumably induced by binding of a 
nonexchangeable Ca  ~+ ion that is trapped in the com- 
plex. 
ELSOLIN (G) is a 90,000-mol-wt Ca2+-binding, actin- 
associated protein that is found in a variety of  tissues 
(l 8, 21). Brevin (B) is a plasma protein closely  related 
to gelsolin, with a molecular weight of 92,000 (6, 9,  10,  16) 
that has been shown to have an additional sequence of 25 
amino acids at its amino-terminal end (22, 24). Gelsolin and 
brevin are reported to sever actin filaments (6, 14, 16, 25) and 
both molecules show a  Ca  z+  dependence  for this  activity. 
Gelsolin has been shown to have two Ca2+-binding  sites each 
with a Ko of ~1  ~M (5, 25). Both gelsolin and brevin will 
form complexes with G-actin (A) (5, 7, 11, 23). Using nitro- 
benzoxadiazol-actin,  we have established that gelsolin has 
two actin-binding sites (5). These can be distinguished by the 
stability of the complexes they form with actin. GA,Ca,  is 
extraordinarily stable even in the presence of EGTA and can 
be isolated by a variety of  methods (2, 13, 14). While GA2Ca2 
can be isolated by gel filtration or sucrose gradient sedimen- 
tation (13), it requires, in contrast to GA,Ca~, the presence of 
micromolar Ca  2+ concentrations for stability. We refer to the 
nonexchangeable or slowly exchanging actin and Ca2+-bind  - 
ing sites that are occupied in the EGTA-stable complex as 
actin site I and calcium site I, respectively, and will refer to 
the more rapidly exchanging sites as actin site II and calcium 
site II, respectively.  The complexes will cap the preferred end 
of actin filaments and slow dilution-induced depolymeriza- 
tion (3) or serve as nuclei when added to G-actin solutions 
under polymerizing conditions  (14, 20,  23). The  capping/ 
nucleation function appears to be less Ca  2+ sensitive (14, 26) 
than the severing function. Brevin has also been shown to cap 
and nucleate actin  filaments (7). We have shown that the 
complexes will cap  but  not  cut  actin  filaments  and  that 
severing only occurs if site I is unoccupied when gelsolin is 
mixed with F-actin (3). 
There is relatively little evidence for ligand-induced confor- 
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hydrodynamic behavior of platelet gelsolin and gelsolin-actin 
complexes (13) and neither show appreciable changes in their 
Stokes radius or sedimentation value in the presence of EGTA 
or 100 uM CaC12. Gelsolin, for example, has a Stokes radius 
of 4.15  nm and an S value of 5.2  in either case. This is in 
marked contrast to the large conformational change which 
accompanies the binding of Ca  2+ by villin, an actin-severing 
protein isolated from microvilli (12).  This large conforma- 
tional change  is associated with Ca  2÷ binding to an  8,700- 
mol-wt fragment, the "head piece," and does not occur when 
Ca  2+ binds to villin core (12). We now report the identification 
of two murine monoclonal antibodies, 8G5 IgG and 4F8 IgA, 
that recognize conformational differences between the Ca  2+- 
liganded and -unliganded forms of gelsolin and brevin. One 
of these antibodies, 8G5 IgG, detects changes in both gelsolin 
and  brevin  that  appear  to  occur  when  calcium  site  II  is 
occupied  in  GCa2  or  BCa2.  The  other,  4F8  IgA,  detects 
changes in brevin and gelsolin that appear to be associated 
with binding a Ca  2÷ ion at site I to form BCa~ or GCa~. These 
conformational changes do not require the presence of actin. 
Materials and Methods 
Preparation of  Hybridomas 
Male BALB/c mice received a primary immunization  with ~20/~g of purified 
human gelsolin-actin  complex and were subsequently immunized  with  10 #g 
of the immunogen at 2-wk intervals over a period of ~3 mo. When high titer 
serum immunoglobulin  was detected, the animals were boosted with  10 ~g of 
immunogen on 3 consecutive d, and then sacrificed. A cell suspension was 
prepared in Dulbecco's modified Eagle's medium (DME) ~  and 200 x  10  ~  spleen 
cells were mixed with 67 ×  106 A653 mouse myeloma cells then pelleted by 
centrifugation at 200 g for 5 rain. Fusion was induced by resuspending the cell 
pellet in 40% polyethylene glycol in DME and incubating  at 37"C for 4 rain. 
Cells were pelleted and slowly resuspended  in DME  plus  10%  hybridoma- 
screened fetal calf serum (M.A. Bioproducts, Walkerville, MD) over 5 min, 
incubated for 15 rain at 37"C, then distributed to 96-well microtiter plates pre- 
seeded with  mouse peritoneal  macrophages.  24  h  later an equal  volume  of 
DME containing  10%  fetal calf serum and 2 x  10  -4 M hypoxanthine,  3.2  x 
10  -6 M thymidine,  and 8 ×  10  -6 M methotrexate  was added to each well to 
select for hybridomas.  After 2 wk of growth, the plates were screened by an 
enzyme-linked immunosorbent assay (ELISA) and the cells from positive wells 
were expanded to 24-well plates. These wells were screened a second time by 
immunoblotting  (19) on whole platelet extracts fractionated on polyacrylamide 
gels (15). The wells that  were positive on the ELISA and immunoblots were 
cloned by single-cell deposition onto thymocyte-seeded 96-well microtiter plates 
using an Ortho Cytofluorograf 50H (Ortho Instruments, Westwood, MA). The 
clones were tested for antibody production by ELISA, immunoblot, and indirect 
immunofluorescence. 
ELISA 
ELISAs were used to identify hybridomas  secreting antibody  against gelsolin. 
Briefly, 0.5 ug of partially purified gelsolin-actin  complex was absorbed to 96- 
well plates (Falcon Micro Test II1, Falcon labwa~e, Becton, Dickinson & Co., 
Oxnard,  CA). The plates were blocked with  10%  calf serum in phosphate- 
buffered saline (PBS), washed with PBS plus 0.05% Triton X-100, and incu- 
bated  with  harvest  fluid. After washing, the  bound mouse antibodies  were 
detected using goat antimouse IgG antibody conjugated with horseradish per- 
oxidase (Cappel Laboratories, Cochranville, PA). The bound horseradish per- 
oxidase-labeled antibody was detected using 2,2'-Azino-di-[3-ethyl-benzthiaz- 
din-sulfonate(6)] Diammonium salt with 0.02% H202 in 0.2 M Na-citrate at 
pH 4.0. Plates were read  using an MR580  Microelisa Dynatech  auto plate 
reader (Dynatech Laboratories Inc., Alexandria, VA) interfaced to an IBM-PC. 
A positive result was scored for wells with an OD at 405 nm greater than 0.4- 
0.5. 
Abbreviations used in this paper:  DME,  Dulbeccos's modified Eagle's me- 
dium; ELISA, enzyme-linked immunosorbent assay. 
Immunoblotting 
Routine  immunoblotting was done  following the methods of Towbin  et al. 
(19). In some experiments we have tested the effects of EGTA on the binding 
of individual  monoclonal  antibodies.  In  these  experiments,  proteins  were 
separated  by  SDS gel  electrophoresis  and  transferred  electrophoretically  to 
nitrocellulose filters (Type GS, 0.22 t~m, Millipore/Continental  Water Systems, 
Bedford, MA) in 0.192 M giycine, 0.025 M Tris, 20% methanol. The nitrocel- 
lulose sheets were then blocked  in 3% bovine  serum albumin plus  5%  calf 
serum in PBS with 0.1% NaN3 for 12-18 h. The sheets were divided and one- 
half were washed 3 times with Triton X-100-PBS plus 5 mM EGTA while the 
other half were washed with PBS plus 0.05% Triton X-100 plus 0.1 mM CaCl2. 
The sheets were then incubated  for 2 h at 37°C with harvest fluids with and 
without 8 mM EGTA. To remove unbound antibody the sheets were washed 
three times in PBS plus 0.05% Triton  X-100 either with Ca  2+ or with EGTA, 
but without NAN3. A fourth wash was done in PBS plus 0.05% Triton X-100 
and Ca  2+ to return all the nitrocellulose sheets to the same buffer. The second 
step antibody was added and incubated at 37°C for 2 h. Finally, the sheets were 
washed three  times with PBS plus 0.05% Triton X-100 without  NaN3 then 
incubated with substrate, 4-chloro -l-naphthol (Sigma Chemical Co., St. Louis, 
MO). The reaction was stopped after 5-30 rain by washing with distilled water. 
Cross-reactivity of  Anti-gelsolin Antibodies 
To prepare extracts from several different types of cultured  cells, -1-2 x  106 
cells of each type were washed with PBS, scraped into hot sample buffer, and 
heated at 90"C for 5 min. These whole cell extracts, along with platelet extract 
prepared  as described previously (2,  14) and partially purified gelsolin-actin 
complex were run on 7.5-15%  SDS polyacrylamide gradient gels and either 
stained with Coomassie Blue or transferred to nitrocellulose and blotted with 
antibody-containing  harvest fluid. 
Antigen Digestion Experiments 
Partially purified gelsolin-actin  complex was digested with trypsin  at molar 
ratios of 100:1 and 1,000:1. Time points were taken at 0,  10, 30, 90, and 240 
min by addition  of hot SDS electrophoresis sample buffer followed by heating 
for 3 rain at  100*C. Alternatively diisopropylfluorophosphate  was added to 2 
mM  to stop the  reaction  before SDS addition.  Samples were run on  15% 
polyacrylamide gels (15) and were either stained with Coomassie Blue or were 
electrophoretically  transferred  to nitrocellulose,  and then blotted  with  anti- 
gelsolin antibodies (19). 
Growth in Serum-free Medium 
The 8G5 or 4F8 hybridomas  were grown in CEM serum-free media supple- 
mented with transferrin, insulin, and selenium (Scott Laboratories, Inc., Fiske- 
ville, RI) at an initial density of 2.5 x  105 cells per cm  2 in T-175 flasks (Falcon 
Labware). After 3 d, the medium was removed and separated from the cells by 
low speed centrifugation at 200 g for 5 rain. The cells were gently resuspended 
in fresh medium and seeded into T-175 flasks. Approximately 5 liters of serum- 
free medium were processed to obtain purified antibody. 
Concentration of Serum-free Medium and Purifica- 
tion of  Antibodies 
Serum-free harvest fluid was concentrated  ~ 15-fold using a MiUipore Minitan 
system (Millipore/Continental  Water  Systems). The IgG in  the  concentrate 
from 8G5 was purified on Protein A-agarose  (Sigma Chemical Co.) (8). The 
recovery was ~ 110 mg of  8G5 lgG per 5 liters of  serum-free medium determined 
using an extinction coefficient of 1.4 at OD~o for a concentration  of 1 mg/ml. 
The IgA in the concentrate  from 5 liters of 4F8 harvest fluid was purified by 
(NH4)2SO4 precipitation  and chromatography  on G-150 Superfine. The final 
yield was ~40-50 mg per 5 liters of serum-free medium. 
Coupling of  Antibody to Cyanogen 
Bromide-activated Agarose 
Purified 8G5 lgG or 4F8 IgA was dialyzed exhaustively against 0.5 M NaCI, 
0.1  M NaHCO3, pH 8.8, then coupled to CNBr-activated Sepharose 4B (Sigma 
Chemical  Co.) following the  procedures  outlined  by Pharmacia  (Pharmacia 
Fine Chemicals, Piscataway, N  J). Briefly, the CNBr-Sepharose  was hydrated 
by washing five times in  1 mM HCI. The final gel pellet was washed rapidly 
with 0.5 M NaCI, 0.1  M NaHCO3, pH 8.8, and then resuspended in approxi- 
mately an equal volume of 8G5 antibody solution at 9 mg/ml in 0.5 M NaCI, 
0.1  M NaHCO3, and allowed to react overnight at 4"C with gentle agitation. 
The supernatant  was removed by centrifugation at 2,500 g for 2 rain and the 
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4°C. The centrifugation was repeated and the gel was washed once with 0.5 M
NaCI, 0 .1 M NaHC03, pH 8.8, once with 0.5 M NaCl, 0.1 M sodium acetate,
pH 4 .0, and once with 0 .5 M NaCl, 0 .1 MNaHC03, pH 8 .8 . Finally, the 8G5
IgG-Sepharose was packed in a column measuring -2 .0 x 3 .5 cm, and
equilibrated with Tris-saline at pH 8.0. We estimate the coupling efficiency at
-v90% . Similar procedures on a somewhat reduced scale were used for the
preparation of the 4Fß IgA-Sepharose .
Platelet Extract Preparation
Human plateletswere washed and high salt extracts were prepared as described
previously (13, 14), modified as indicated by Bryan (2) . The high salt extracts
were dialyzed against 40 mM KCI, 0 .1 mM EGTA, 10 mM imidazole, pH 7.2
to produce a contractile gel consisting principally of actin, myosin, actin-
binding protein, alpha-actinin, and tropomyosin . Some gelsolin was lost at this
step, presumably by binding to filament ends. For isolation of gelsolin-actin
complexes, GA,Ca, and GA2Ca2, the contractile material was removed by
centrifugation at 100,000 g for 60 min and the resulting supernatant was
dialyzed against 40 mM KCI, 0.1 MM CaC12, 1 .0 mM NaN 3, and 10 mM
imidazole, pH 7 .2 . Alternatively, the supernatant was dialyzed against 6 M
urea, 0 .1 mM EGTA, 1 .0 mM NaN3 , and 10 mM imidazole, pH 7 .2, to
dissociate gelsolin-actin complexes . The urea was then removed by dialysis
against 40mM KCI, 0.1 M CaCl2, 1.0mM NaN3, 10 mM imidazole, pH 7.2 .
We have shown previously that, under these conditions, gelsolin either is not
denatured or renatures easily (5).
Preparation ofSerumfor Brevin Isolation
The citrated plasma recovered after platelet isolation was used to prepare
human brevin . The plasma was centrifuged at 20,000 g for 30 min. The
supernatant was then dialyzed against 140 mM NaCl, 3 mM CaC1 2, 1 .0 MM
NaN3, 10 mM imidazole, pH 7.2, to induce clot formation . The dialysis was
done at room temperature with three changes ofbuffer using 4 liters ofbuffer
per liter ofplasma per change. The fibrin clot was removed by centrifugation
at 20,000 g for 20 min. This serum was rapidly frozen in 50-ml aliquots in
liquid nitrogen and stored at -70°C. Before use, 50-100 ml were thawed and
centrifuged at 100,000 g for 60 min . The supernatant was used for brevin
isolation .
Miscellaneous
SIDS polyacrylamide gels were run according to Laemmli (15) . Immunoblots
were done following Towbin etal. (19) . Proteinconcentrationswere determined
by a modification of the Bradford method (I) using bovine serum albumin as
a standard .
Results
Characterization ofAnti-Gelsolins
We have characterized antigen-antibody binding using sev-
eral procedures including (a) immunoblotting of various cell
extracts, (b) immunoblotting of intact and proteolytically
fragmented gelsolin, (c) immunoblotting ofgelsolin either in
the presence of Ca" or EGTA, and (d) by analyzing the
material retained by antibody coupled to Sepharose . We have
identified the antibodies produced by 8G5 as an IgG and by
4178 as an IgA using antibody typing reagents and by compar-
ison of the molecular weights of their heavy and light chains
with known standards by SDS PAGE (data not shown) .
The results of the blotting experiments for the various cell
extracts and for intact and fragmented gelsolin are shown in
Figs . 1 and 2 . Immunoblots of complex mixtures of protein
from human platelets, WI-38 cells, orhuman foreskin fibro-
blasts gave a single reactive component of 90,000-mol-wt that
migrated with purified gelsolin standards (Fig . 1) . The two
nonhuman cell types, 3T3 andNRK/RSV cells, did not cross-
react at the protein concentrations used here . The immuno-
blots of the partial tryptic digests, Fig. 2, suggest that the
epitope for 8G5 IgG is located on a peptide near one end of
gelsolin since cleavage to a 70,000-mol-wt fragment greatly
reduced cross-reactivity . 4178 IgA appears to recognize an
epitope deeper in the molecule since it cross-reacts with both
the 70,000-mol-wt peptide and a 50,000-mol-wt peptide . In
additional cleavage experiments with other proteases,we have
shown that both the 4178 and 8G5 epitopes are on the C
terminal half of brevin (4) .
Note that there was no evidence for a cross-reaction with
actin in any of the immunoblotting experiments. In the
platelet extractswe estimate that the relative concentration of
Figure 1 . Immunoblots of cell and platelet ex-
tracts and partially purified gelsolin-actin com-
plex . Coomassie Blue-stained gels, on the left,
are shown paired with corresponding immuno-
blot(s), on the right. 8G5 harvest fluid was used
unless otherwise indicated. Lane A, molecular
weight markers : 94,000, phosphorylase B ; bovine
serum albumin, 68,000 ; ovalbumin, 43,000 ; car-
bonic anhydrase, 30,000; soybean trypsin inhib-
itor, 21,000; lysozyme, 14,300. Lanes B and C,
Swiss 3T3 cells. LanesD and E,RSV/NRK cells .
Lanes F and G, human foreskin ftbroblasts .
Lanes H and I, WI-38 cells. Lane J, platelet
extract . LanesK and L, immunoblots with 4178
(K) and 8G5 (L) harvest fluids. No reactivity
was detected with NRK/RSV and 3T3 cells
whereas a single band at 90,000-mol-wt was
stained in each of the other samples.
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Hwo and Bryan Conformational Changesin Gelsolin and BrevinFigure 2.  Characterization of anti-gelsolin antibodies. Partially purified gelsolin-actin complex ( 1 mg/ml) was digested with trypsin at molar 
ratios of 100:l (lanes 1-5) and 1,000:l  (lanes 6-9). Time points were taken at 0 (lane 1),  10, 30, 90, and 240 (lanes 2-5 and 6-9) min; 
proteolysis was stopped by addition of SDS PAGE sample buffer. Four identical 15% gels were run: a Coomassie Blue-stained gel is shown in 
A. The molecular weight standards are the same as those shown in Fig. 1. Their positions are marked with small arrowheads on the left side. 
After electrophoretic transfer to nitrocellulose, immunoblots were done using the three  monoclonal anti-gelsolin antibodies. B shows the 
fragment staining pattern using 8G5 IgG and C shows the staining pattern using 4F8 IgA. 
actin must be 50-100 times greater than gelsolin, yet the actin 
band was never stained. Similarly,  we have done immunoblots 
on rabbit skeletal muscle actin and detected no cross-reactivity 
with actin bands of 5-15 gg and purified 8G5 IgG concentra- 
tions of 10-50 gg/ml. Under the same blotting conditions, 
however,  we  could detect  1-2  t~g of human gelsolin using 
<0.1 #g/ml of purified 8G5 lgG. 
The Antibodies Recognize 
Ca~+-induced Conformations 
Fig. 3 demonstrates the specificity of the 8G5 and 4F8 anti- 
bodies for specific Ca2+-induced gelsolin conformations. Var- 
ious concentrations of a  partially degraded gelsolin prepara- 
tion were run in duplicate on SDS polyacrylamide gels then 
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4F8  IgA recognize  a  Ca++-induced  con- 
formation. A crude preparation of gelso- 
lin containing some breakdown products 
was separated on 10% SDS polyacrylam- 
ide gels, then transferred to nitrocellulose 
as described in Materials and Methods. 
The individual lanes were loaded with 3, 
1, 0.5, 0.1, and 0.05  ug of total protein; 
the gels and nitrocellulose filters were re- 
produced  six  times.  The  filters  were 
washed  with either Ca  2÷- or EGTA-con- 
taining buffers then exposed to the mouse 
antibodies in  Ca  2+  or  EGTA.  The  un- 
bound mouse antibodies were washed off 
with Ca  2÷- or EGTA-containing media, 
then  all filters  were  processed  in  Ca  2+- 
containing media with second-step anti- 
bodies conjugated to horseradish peroxi- 
dase.  The top three panels show the re- 
sults  for  8G5  (left),  4F8  (center),  and 
mouse polyclonal antibodies  (right) when 
Ca  2÷  was  present during  the  first  anti- 
body-binding  step. The lower three panels 
show the result when EGTA was present 
during the same binding step. 
transferred to nitrocellulose filters. The filters were cut in half 
and  incubated with  either 8G5  or 4F8  antibodies in  either 
Ca  2+- or 1 mM EGTA-containing solutions. The results show 
that both antibodies have different affinities for gelsolin de- 
pending upon  the  presence  of Ca  2+  or EGTA,  and  gave  a 
strong positive signal if Ca  2÷ was  present but  showed  little 
recognition in the absence of Ca  2+. In the presence of Ca  2÷, 
8G5 IgG reacted strongly with a  single band at 90,000-mol- 
wt,  but gave only a  barely detectable signal with  -2  ug  of 
human  gelsolin if EGTA  was  present during the  antibody- 
binding step.  4F8  IgA, under  the  same conditions, reacted 
strongly with the 90,000-mol-wt species and with fragments 
at  63,000,  53,000,  and  47,000-49,000-mol-wt.  A  murine 
polyclonal antibody, used here as a control, did not show any 
particular sensitivity to  Ca  2÷  levels although  there  is some 
attenuation of the signal on immunoblots (Fig. 3). 
Note that although we have not directly demonstrated Ca  2+ 
binding  to  gelsolin  after  electrophoresis in  SDS,  we  have 
shown that gelsolin will bind ~25I-actin in an overlay proce- 
dure (l 7) and that this binding is strongly promoted by added 
Ca  2+ (18). 
Purification of Gelsolin-Actin Complexes Using 
8G5 IgG 
The affÉnity of 8G5 IgG for a  Ca2+-induced conformation of 
gelsolin provides a  facile method for purification of gelsolin 
and brevin. The results of one gelsolin purification done at 
higher ionic strength, 300 mM KCI, are shown in Fig. 4. An 
8G5 IgG-Sepharose column, equilibrated with 300 mM KC1, 
0.1  mM  CaCI2,  1.0  mM  NAN3,  and  10  mM  imidazole, pH 
7.2,  was  loaded  with  a  gelsolin-containing platelet extract 
adjusted to 0.1  mM Ca  2+. The same buffer was used to wash 
the column after loading until the concentration of protein in 
the eluate was <5 #g/ml. The bound protein was eluted with 
300  mM  KC1,  4  mM  EGTA,  1.0  mM  NAN3,  and  10  mM 
imidazole at pH 7.2. The protein concentration of the initial 
231  Hwo and Bryan Conformational Changes in Gelsolin  c"4 Brevin Figure 4.  Immunoaftinity  purification of the gelsolin-actin complex. A platelet cytosoi preparation containing Ca  2÷ was applied to the 8G5 
lgG-Sepharose column. The preparation of the extract and the 8G5 IgG-Sepharose are described in Materials and Methods. Briefly, 25 ml of 
extract at -10 mg/ml was diluted to 3.0 mg/ml at a final KC1 concentration of 0.3 M and a final Ca  2+ concentration of 0.1 mM then loaded 
on the column. The top panel shows the Coomassie Blue-stained gel of selected fractions. The lower panel shows the protein profile. In this 
run, the buffer was switched to 0.3 M KC1 + 4 mM EGTA at the arrow. The fraction size was 10 ml from fraction 1 to 22 and 1.0 ml from 
fraction 23 on. Note that the actin that is not complexed with gelsolin is not retained by the antibody. 
extract was 3-4 mg/ml and we routinely recover 20-40 ~g of 
gelsolin per ml of this extract. This can be used to provide a 
minimum  estimate for the concentration  ofgelsolin in platelet 
extracts, but does not account for gelsolin that sediments with 
the contractile gel or that may sediment when the particulate 
fraction is removed. The average recovery from four experi- 
ments was 0.65 mg of gelsolin per  100 mg of protein in the 
original high salt extract. The ratio of actin to gelsolin in the 
fractions eluted with EGTA is greater than one but less than 
two, indicating that a  mixture of GA, and GA2 and perhaps 
higher oligomers bound to the antibody. We have established 
previously that  GAtCa,  is  stable in  EGTA (14)  and have 
chromatographed the fraction eluted from 8G5 IgG-Sepha- 
rose on Agarose A5m to establish that the eluted species is 
GA,Ca,. The results (not shown) indicate that a  130,000-mol- 
wt species containing  actin and gelsolin is present. Finally, we 
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Kurth and Bryan (13). This was loaded on 8G5 IgG-Sepharose 
after addition  of Ca  2+  to  0.1  mM.  The  45Ca2+ eluted  after 
EGTA addition  and was complexed with GA, as judged by 
chromatography on agarose A5m. The results strongly indi- 
cate  that  the  conformation  recognized  by the  8G5  IgG is 
induced or stabilized by the binding of the second Ca  2+ ion 
to gelsolin. We note that 8G5 IgG does have low affinity for 
other unliganded  forms of gelsolin since  loading a  platelet 
extract dialyzed  versus 0.1  or  1 mM  EGTA results  in  the 
partial retention of gelsolin-actin complexes with elution as a 
distinct  trailing  shoulder  on  the  main  protein  peak.  This 
agrees with the low level of binding of the antibody in EGTA 
to the highest concentrations of gelsolin in the immunoblots 
shown in Fig. 3. 
Our absolute yield of gelsolin per column run is -5-6 mg 
of protein, a  value obtained by summing the protein across 
the  gelsolin  peak.  Loading  the  column  with  more  extract 
results in gelsolin appearing in the unbound protein fraction. 
We calculate, therefore, that only 8  to  10%  of the coupled 
antibody can bind with the antigen. We have not systemati- 
cally varied the antibody to CNBr-Sepharose ratios to try to 
optimize for active antibody. 
Purification of  Free Gelsolin or Brevin 
To demonstrate the usefulness of 8G5 IgG and also to see if 
a complexed actin was required for antibody recognition, we 
have purified  both gelsolin  and  the  closely related  plasma 
protein, brevin, directly. To purify gelsolin from platelets, it 
is necessary to  split the  gelsolin-actin complexes that  form 
spontaneously (13).  We have used dialysis against 6  M  urea 
to break these complexes (13) as described in Materials and 
Methods. The strategy was to dialyze versus urea and EGTA 
to weaken the complex and eliminate ATP to maximize the 
denaturation  of actin.  The urea was then removed and the 
Ca  2÷ level raised by dialysis.  Chromatography of this material 
under the same conditions used for isolation of the gelsolin- 
actin complex yielded free gelsolin.  8G5 IgG-Sepharose did 
not retain actin unless it was complexed to gelsolin.  To test 
further whether  actin  was  necessary for the  recognition  of 
gelsolin by 8G5 IgG, we have used the antibody column in 
the purification of human plasma brevin. The result is shown 
in  Fig.  5.  80-100  ml  of serum  prepared  as  described  in 
Materials and  Methods were loaded on  8G5 IgG-Sepharose 
and  eluted  with  EGTA.  In  this  particular  experiment,  the 
serum was loaded in  140 mM NaC1, 3 mM CaC12, 1.0 mM 
NAN3, l0  mM imidazole at pH 7.2.  The column was then 
washed with 0.3 M KC1, 0.1  mM CaCl2,  1.0 mM NAN3, and 
l0 mM imidazole at pH 7.2. Brevin was eluted by substituting 
4  mM  EGTA  for 0.1  mM  CaCl2  in  the  same buffer.  The 
eluted  material  consisted  of brevin  and  small  amounts  of 
human IgG heavy and light chains which appeared to stick 
either to the mouse IgG or to the agarose even in high salt. 
Their concentration could be reduced by prolonged washing 
Figure 5.  Immunoaffinity purification of human serum brevin. Citrated human plasma was dialyzed against Ca2+-containing buffers to induce 
clotting as described in Materials and Methods.  The serum,  100 ml at 38  mg/ml, was loaded on an 8G5  IgG-Sepharose column.  In this 
experiment, the buffer was switched to 0.3 M  KC1 plus 0.1  mM CaCI2 at the first arrow and to 0.3 M  KC1 plus 4 mM EGTA at the second 
arrow. The fraction size was  10 ml from fraction 1 to  17, 5 ml from fraction 18 to 25, and 1 ml from fraction 26 on. Selected fractions were 
analyzed by SDS PAGE and are shown in the inset. The fractions, from left to right, are numbers 34, 36, 38, 40, 42, and 44. 
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routinely recover -50-100 ug of brevin per ml of serum. A 
similar result was obtained using urea-treated platelet extracts; 
gelsolin was the  major component eluted with EGTA.  The 
absolute yield of brevin, -5-6 mg, was the same as described 
above for gelsolin.  These results demonstrate that  8G5 IgG 
recognizes both gelsolin and brevin. 
Activity Assays 
We have tested both the gelsolin, gelsolin-actin  complexes, 
and brevin eluted from 8G5 IgG-Sepharose for their  ability 
to cap or sever filaments. The gelsolin preparations are equiv- 
alent  to  those  we  have  prepared  using  DNAse  I-agarose 
affinity chromatography (2, 20) or more standard biochemical 
methods  (2,  14).  The  brevin  purified  by  immunoaffinity 
chromatography is  active  both  in  severing  and  nucleation 
assays (data not shown). 
Comparison of 8G5 IgG and 4F8 IgA-Sepharose 
We have used 4F8 IgA-Sepharose to purify brevin from serum 
with results identical to those described in Fig. 5 for 8G5 IgG- 
Sepharose.  Brevin was retained  in 0.1  mM Ca2+-containing 
buffers and released by 4 mM EGTA-containing buffers. We 
have also prepared brevin-actin-Ca  2+ complexes by mixing 
purified brevin with a  2.5-fold molar excess of actin in 0.2 
mM CaC12, 50  mM  NaC1,  2  mM  Tris-HC1,  pH 8, and 0.5 
mM  ATP.  Chromatography  of this  material  on  4F8  IgA- 
Sepharose, shown in Fig. 6, gave markedly different results. 
The complex, BAICa~, was retained even in  10 mM EGTA 
and  0.6  M  NaC1,  but  was  released  by elution  with  0.1  M 
glycine-HCl, pH 2.8. Finally, we have equilibrated the com- 
plex with 1 mM EGTA and loaded this on 4F8 IgA-Sepharose 
equilibrated with buffers containing 1 mM EGTA. The com- 
plex was retained, but could be eluted at pH 2.8 as shown in 
Fig. 7. 
A  summary of the binding behavior of the various forms 
of brevin and gelsolin-actin complexes on the antibody col- 
umns  is  given  in  Table  I.  We  have  tested  all  the  possible 
combinations and find that binding of all species with  8G5 
requires  Ca  2÷, while  4F8  retains  brevin-actin  and gelsolin- 
actin complexes in Ca  2+ or EGTA. 
Discussion 
This report demonstrates the usefulness of immunopurifica- 
tion for gelsolin and brevin. We can obtain milligram quan- 
tities  of either protein  in  1 or 2  d.  In addition,  the  results 
demonstrate the specificity of two monoclonal antibodies, an 
IgG  and  an  IgA,  for  CaE+-induced  conformations  in  the 
gelsolin  molecule.  The  initial  immunogen  was  the  actin- 
gelsolin complex, GAICa~, but neither of the antibodies rec- 
ognizes actin on immunoblots. In addition,  neither 4F8 IgA 
Figure 6.  Chromatography of brevin-actin complex on 4F8 IgA-Sepharose. Approximately 600 #g of brevin-actin complex was loaded on a 
10-ml column of4F8 IgA-Sepharose equilibrated with 0.3 M NaC1 plus 0.1 mM CaC12 in l0 mM imidazole, pH 7.2, 2 mM NAN3. At the three 
arrows the column was sequentially eluted with 0.3 M NaC1 plus 5 mM EGTA, 0.6 M NaC1 plus  l0 mM EGTA, both in l0 mM imidazole, 
pH 7.2, and then with 0.1 M glycine-HCl at pH 2.8. The fraction size was 0.8 ml. The insets show SDS gels from fractions  14 and 16 in the 
first peak and from 114 and 115 in the second peak, respectively. 
The Journal of  Cell Biology,  Volume 102, 1986  234 Figure  7.  Chromatography of brevin-actin complex on 4F8 IgG-Sepharose in EGTA. Approximately  1.0 mg of brevin-actin complex was 
dialyzed exhaustively against 0.3 M NaCI, 1 mM EGTA, 2 mM NAN3,  and I0 mM imidazole, pH 7.2, then loaded on the 4F8 IgA-Sepharose 
column described in Fig. 6 equilibrated  with the EGTA-containing  dialysis buffer. The material  that is not retained  is mainly excess actin. 
Elution  with  0.1  M glycine-HC1, pH 2.8, at the arrow,  releases the brevin  and actin.  Preliminary  characterization  indicates  that low pH 
dissociates the complex, presumably by denaturing  the actin. The brevin does retain severing activity. The fraction size was 0.8 ml. Selected 
fractions were analyzed by SDS PAGE and are shown in the upper panel. The first lane shows the profile for the starting material. 
nor 8G5  IgG-Sepharose retains  actin  unless  it is associated 
with gelsolin. Using 4F8 IgA and 8G5 IgG-Sepharose we have 
characterized  the  antigen-antibody  reactions.  At  free  Ca  2÷ 
concentrations  that  will  saturate  the  Ca2÷-binding  sites  of 
gelsolin, whose KD's are ~ 1 #M, the antibodies retain GA,Ca2 
and  possibly  higher  oligomers  containing  additional  actin 
monomers from  extracts  prepared  from  activated  platelets. 
The addition of EGTA, which will remove one bound Ca  2÷ 
from GA,Ca2,  but  not the  other (13),  releases  the  retained 
gelsolin and actin from 8G5 IgG, but not 4F8 IgA-Sepharose. 
The  material  released  from 8G5  IgG-Sepharose chromato- 
graphs on gel-filtration as a  130,000-mol-wt species with the 
characteristics of GAICa, (13). Our interpretation is that 8G5 
IgG recognizes GA2Ca2 with high affinity, hut has a markedly 
reduced affinity for GA,Ca,.  We have  done similar experi- 
ments  with  reconstituted  brevin-actin  complexes  with  the 
same  results.  4F8  IgA, on  the  other hand,  recognizes both 
GA,Ca,  and BA~Ca,  with high affinity and will retain these 
complexes in the presence of EGTA. 
The behavior of gelsolin is the same as the gelsolin-actin 
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Antibody  Actin  Gelsolin  Brevin  Gelsolin-Actin*  Brevin-Actin* 
8G5 lgG  0  1  1  1  1 
4F8 lgA  0  1  1  2  2 
* These proteins were tested as pre-formed complexes. 
0, no binding in Ca  2+ or EGTA. 
1, binding in Ca  2÷, no binding in EGTA. 
2, binding in Ca  2+ and in EGTA. 
complexes  on  8G5  IgG-Sepharose  and  we  infer  that  this 
antibody binds GCa2,  more tightly than G or GCa~ and that 
actin is not important for these interactions. The same con- 
clusions hold for brevin. This altered affinity must reflect a 
conformational change in gelsolin or brevin that occurs when 
a Ca  2+ ion binds at calcium site II, the more easily exchange- 
able  site.  The  conformational change  appears  to  be  small 
since we have not detected changes in the Stokes radius or 
sedimentation value of gelsolin in the presence of Ca  2+ or 
EGTA (13). On the other hand there is a marked difference 
in the binding affinity at actin site II between GAjCa~  and 
GA~Ca2  (5).  We  have estimated the KD for binding  of the 
second  actin  to  be  30  nM  for GA~Ca~ and  <0.1  nM  for 
GAICa2. 
4F8  IgA  must  recognize  a  second  conformation  since 
GAtCa~ and BAtCaj are retained by 4F8 IgA-Sepharose. Actin 
does not appear to be required for the conformational change 
recognized by 4F8  IgA since brevin, as BCa2, is retained by 
the column. However, as we have shown previously (13), the 
gelsolin-actin-Ca 2÷ complex, GA~Ca~ traps a Ca  2+ ion and is 
stable in  EGTA.  We  have shown that BA~Ca~ also traps a 
Ca  2÷  ion  (J.  Bryan,  unpublished  data).  The  present results 
show that an  actin  bound at  actin  site  II  can  stabilize the 
brevin or gelsolin conformation recognized by 4F8  IgA and 
prevent elution with EGTA. We infer that this conformation 
is induced by binding of a Ca  2+ ion at calcium site I, where it 
is then trapped in the complex. 
Finally, we cannot pinpoint where the physical location of 
the conformational change recognized by 8G5  IgG is within 
the protein using the immunoblots of the proteolyzed frag- 
ments shown in Fig.  2. The data suggest that the removal of 
a  20,000-mol-wt  piece  destroys  8G5  IgG  recognition.  We 
have been unable to recover this 20,000-mol-wt fragment and 
demonstrate CaE+-sensitive  antibody binding. 4F8 IgA recog- 
nizes a separate epitope that is present on several proteolytic 
fragments  with  molecular weights  of 63,000,  53,000,  and 
47,000-49,000.  Each of these fragments appears to retain a 
calcium-binding site since Ca  2+ is required for antibody rec- 
ognition. Our preliminary results with other proteases indicate 
that both epitopes are on the C terminal half of the molecule 
(4).  The  NHE-terminal  half of the molecule has the  actin- 
binding  domains  and  retains  all  of the  filament  severing 
activity.  Proteolysis  separates  the  Ca  2+o  and  actin-binding 
domains and produces fragments that sever but are no longer 
regulated by Ca  2+. We are currently working to understand 
the interactions between these domains on gelsolin and brevin 
molecules. 
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